title: Autologous bone marrow transplantation for Hodgkin's disease.
abstract: Autologous bone marrow and/or peripheral blood stem cell transplantation is being performed increasingly frequently as a treatment for Hodgkin's disease. While patients with refractory disease can sometimes be cured, the results are better in patients who are still chemotherapy sensitive. The use of high dose therapy as part of the primary treatment for high risk patients is now being studied.
authors.affiliation: University of Nebraska Medical Center, Omaha.
authors.forename: J O
authors.initials: JO
authors.lastname: Armitage
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000401:mortality / Q000628:therapy*; D006801:Humans; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents